Navigation Links
MuGard Provides Significant Improvement or Stabilization of Oral Mucositis in Over 75% of Patients in European Clinical Experience
Date:10/11/2010

e Care in Cancer). At that conference, Access presented data from a US clinical trial in patients undergoing radiation and/or chemotherapy for treatment of head and neck cancer showing that 42% of patients using MuGard preventatively never exceeded an Oral Mucositis Assessment Scale (OMAS) score of 0.5. This data underscored MuGard's potential for oral mucositis prevention. The overall comparison showed that patients treated with MuGard had significantly lower OMAS scores when compared to the three control groups. The largest benefit was observed when patients used MuGard on the first day they started cancer therapy and continued using MuGard during the entire duration of treatment. Additionally, MuGard lowered erythema (a precursor inflammatory condition to OM) scores in subjects with various oral inflammatory conditions, including patients with xerostomia, cheilitis and stomatitis. The presentation of clinical experience at the ESMO conference is the culmination of all previously announced European clinical programs.

For additional information on MuGard, including information for clinicians, nurses and patients, please visit www.MuGard.com.

About MuGard:MuGard is a novel, ready-to-use, easy-to-swallow, mucoadhesive oral wound liquid that provides a protective polymer coating over the mucosa.  MuGard received 510(k) marketing allowance in the US with a broad indication for treating lesions of the mouth including the management of oral mucositis. In Europe, MuGard is a class IIa medical device which has been granted CE mark certification with the following indication: prevention and management of the lesions and symptoms of oral mucositis Up to 40% of all patients receiving chemotherapy and radiotherapy develop moderate to severe mucositis, and almost all patients receiving radiotherapy for head and neck cancer and those undergoing stem cell
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
2. Access Pharmaceuticals Signs eMarketing Agreement With iMedicor For MuGard(TM)
3. Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback
4. Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America
5. Access Pharmaceuticals Launches MuGard Product Website
6. Access Pharmaceuticals, Inc. Signs $30M MuGard Supply Agreement With RHEI Pharmaceuticals HK LTD.
7. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
8. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
9. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
10. Raptor Pharmaceuticals Provides Update of Product Programs
11. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... DUBLIN, Ohio, July 30, 2015  Cardinal Health ... $27.5 billion, an increase of 20 percent, and ... operations of $1.00, an increase of 20 percent. ... million. On a GAAP basis, operating earnings increased ... from continuing operations increased 29 percent to $0.88. ...
(Date:7/30/2015)... England , July 30, 2015 ... or "The Group") the regenerative medical devices company, ... within the post-acute wound care market as Tissue ... for DermaPure® under Medicare administrator, First Coast Service ... Florida , Puerto Rico ...
(Date:7/30/2015)... 2015  IDEXX Laboratories, Inc. (NASDAQ: IDXX ) ... of $413 million, an increase of 6% compared to ... the US dollar reduced reported revenue growth by 7%. ... was 11%, supported by strong growth in the Companion ... ("EPS") was $0.60 for the quarter, an increase of ...
Breaking Medicine Technology:Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 2Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 3Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 4Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 5Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 6Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 7Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 8Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 9Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 10Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 11Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 12Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 13Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 14Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 15Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 16Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 17Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 18Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 19Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 20Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 21Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 22Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 23Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 24Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 25Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 26Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 27Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 28Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 29Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 30Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 31Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 32Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 33Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 34Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 35Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 36
... NASHUA, N.H., June 19 iCAD, Inc. (Nasdaq:,ICAD), ... the early identification of cancer, today announced it ... virtual colonoscopy CAD,product, in partnership with ACR Image ... (ACR). iCAD and ACR Image Metrix, having completed ...
... Difficult-to-Treat Skin ... methicillin-resistant Staphylococcus aureus (MRSA), ... FRX ) today announced positive results from two ... with activity against gram-positive bacteria, such as MRSA,and gram ...
Cached Medicine Technology:iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix 2iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix 3iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix 4Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections 2Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections 3Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections 4
(Date:7/30/2015)... ... July 30, 2015 , ... The American Association ... Rosenberg’s announcement of the reinstitution of National Prescription Drug Take-Back Days. The 10th ... 10:00 AM to 2:00 PM local time. On the 26th, the DEA, with ...
(Date:7/30/2015)... ... July 30, 2015 , ... InventHelp, a leading inventor ... a personal-care device that makes it easy to apply lotion or medication to a ... for assistance when applying lotion or medication to the back, and provides thorough coverage. ...
(Date:7/30/2015)... ... 2015 , ... Political unrest is the number one concern ... survey by leading international insurance provider Clements Worldwide. The "Clements Worldwide Risk Index" ... largest sources of financial losses among respondents. , Twenty-eight percent of top managers ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... with its Medicare administrative contractor (MAC) over submitted claims for bariatric surgery that, ... a challenge to program integrity, Becky Dennis, a nurse auditor at WellSpan Health, ...
(Date:7/30/2015)... , ... July 30, 2015 , ... At the presentation of the 2015 Annual Meeting ... focused on research presented by the Journal of Arthroplasty pertaining to how soon ... driving. , Results of the study confirm what Santa Rosa Orthopaedics (SRO) ...
Breaking Medicine News(10 mins):Health News:AAPCC Supports National Prescription Drug Take-Back Day 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 3Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2Health News:New Clements Worldwide Global Risk Survey Shows Political Risk and Instability Top Managers' Concerns 2Health News:New Clements Worldwide Global Risk Survey Shows Political Risk and Instability Top Managers' Concerns 3Health News:Hospital Details Fight for Bariatric Surgery Reimbursement in AIS Newsletter 2Health News:Hospital Details Fight for Bariatric Surgery Reimbursement in AIS Newsletter 3Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 2Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 3
... Medical University ... epidural prefrontal cortical stimulation , CHARLESTON, S.C., Oct. 13 ... with treatment-resistant depression. Bilateral epidural prefrontal cortical stimulation (EpCS) was ... in a small group of patients, according to lead researcher ...
... Package Continues to Provide Daily Requirement of Milk and ... The following was issued today by the Dairy Council ... available to WIC participants has garnered public attention, it ... continue to be strongly supported nutrient-rich options in this ...
... October marks Domestic Violence Awareness month and on October ... professionals across the country will reflect on over 800 ... restored by the American Academy of Cosmetic Dentistry Charitable ... (Photo: http://www.newscom.com/cgi-bin/prnh/20091013/DC91525 ) , ...
... invasive procedures (including the use of robotic assistance) for ... may shorten hospital stays and decrease respiratory and surgical ... of certain complications, including incontinence and erectile dysfunction, according ... JAMA , a theme issue on surgical care. ...
... 13, 2009 Early action, especially rapid rollout of vaccines, ... H1N1 influenza virus, according to a simulation model of a ... CMAJ ( Canadian Medical Association Journal ) ... that projects how many people will be infected under different ...
... finds better short-term results for endovascular repair than for ... A less-invasive method of abdominal aortic aneurysm (AAA) repair ... new U.S. study. , The interim findings are from ... and open surgical repair of AAA. The report included ...
Cached Medicine News:Health News:New Brain Stimulation Treatment May Offer Hope For Those With Treatment Resistant Depression 2Health News:New Brain Stimulation Treatment May Offer Hope For Those With Treatment Resistant Depression 3Health News:With All the Focus on What's New, Milk Remains Tried and True 2Health News:Over 800 Lives of Domestic Violence Survivors Restored by the American Academy of Cosmetic Dentistry Charitable Foundation's Give Back A Smile Program 2Health News:Minimally invasive radical prostatectomy shows advantages, but also certain complications 2Health News:H1N1 simulation modeling shows rapid vaccine rollout effective in reducing infection rates 2Health News:Study Compares Abdominal Aortic Aneurysm Repair Methods 2
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
... Laparoscopic Instruments incorporate a layered design unique ... and monitored to prevent stray electrosurgical burns ... by insulation failure or capacitive coupling; a ... built into all AEM Instruments provides a ...
... Laparoscopic Instruments incorporate a layered design unique ... and monitored to prevent stray electrosurgical burns ... by insulation failure or capacitive coupling; a ... built into all AEM Instruments provides a ...
Medicine Products: